K-pharma to participate in J.P. Morgan Healthcare Conference
By | translator Kim, Jung-Ju
24.01.04 05:50:37
가나다라
0
The J.P. Morgan Healthcare Conference is scheduled to take place in San Francisco, the U.S., from Jan. 8-11.
Yuhan, Hanmi, Dong-A, SK Biopharm, and others are scheduled to participate in the conference with aims to present their key pipelines and business plans
Samsung Biologics and Celltrion will present in the main track, and showcase their mid-to-long-term vision
▲The J.P. Morgan Healthcare Conference is scheduled to take place in San Francisco, the U.S., from Jan. 8-11. (screen captured from J.P. Morgan homepage)
Korean pharmaceutical and biotech firms are fully prepared to attend the J.P. Morgan Healthcare Conference, the first international event of the year. The spotlight is on what accomplishments Korean pharmaceutical and biotech firms might achieve at this event, where they will join global companies to discuss large-scale technology transfers and partnership agreements.
According to the pharmaceutical and biotech firms on the 4th, companies participating in the J.P. Morgan Healthcare Conference include Yuhan Corporation, Hanmi Pharm, Dong-A ST, and SK Biopharmaceuticals. Companies such as Samsung Biologics and Lotte Biologics, with plans to expand their contract development and manufacturing org
(shm@dailypharm.com)
If you want to see the full article, please JOIN US (click)